Market Overview

FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Related AMRN
Amarin Moves Higher On Speculation Of Special Protocol Assessment
Stocks To Watch For June 26, 2014

View Orange Book.

Posted-In: News FDA

 

Related Articles (AMRN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters